South & Central America Pharmaceuticals Market Size and Forecast (2021 - 2031)
The pharmaceuticals market in South and Central America is poised for significant growth, with projections indicating that it will reach a value of approximately US$ 95.3 billion by 2031, up from US$ 69.3 billion in 2024. This growth trajectory reflects a compound annual growth rate (CAGR) of 4.5% from 2025 to 2031, driven by various factors that are reshaping the healthcare landscape in the region.
Market Overview and Growth Drivers
The South and Central America pharmaceuticals market is primarily segmented into key countries, notably Brazil and Argentina, along with other nations in the region. The expansion of this market can be attributed to several critical factors, including a large and growing population, improvements in healthcare infrastructure, increased government investment in healthcare innovation, rising healthcare expenditures, and a heightened demand for medical treatments due to the increasing prevalence of chronic diseases.
Countries like Costa Rica and Brazil are emerging as attractive destinations for medical tourism, offering high-quality healthcare services at competitive prices. This influx of international patients seeking medical care has significantly boosted the demand for pharmaceuticals, particularly as more individuals pursue elective surgeries, cosmetic procedures, and specialized treatments. Brazil, in particular, is home to numerous Joint Commission International (JCI)-accredited hospitals and clinics, ensuring that patients receive care that meets international standards. The state of Pernambuco, with its capital Recife, has become a notable hub for medical tourism, housing over 2,000 healthcare facilities. In 2022, more than 120,000 medical tourists visited Recife for treatment, underscoring the region's growing reputation in the healthcare sector.
Market Segmentation Insights
The South and Central America pharmaceuticals market can be analyzed through various lenses:
The future of the South and Central America pharmaceuticals market is characterized by a shift in power dynamics, with emerging regional players redefining the landscape of pharmaceutical innovation and market focus. Supply chains are expected to diversify strategically, reducing reliance on traditional hubs and enhancing agility in response to global uncertainties. Regulatory frameworks are also anticipated to evolve, incorporating digital tools and fostering cross-border collaborations to streamline approval processes.
According to Oxford Economics, the global pharmaceuticals market, valued at US$ 1.5 trillion in 2023, is on a steady growth trajectory, with expected expansions of 3% in 2024, 4% in 2025, and 3.6% in 2026. This growth is influenced by changing healthcare needs, shifts in supply chains, and evolving regulatory environments. The pharmaceutical industry is undergoing a transformation driven by these factors, alongside increasing demand for specialized medicines and a wave of mergers and acquisitions that are reshaping the competitive landscape. Challenges such as regulatory complexities and cost pressures remain, necessitating greater agility and innovation within the sector.
Country-Specific Insights
Focusing on Brazil, the largest market in the region, the pharmaceuticals sector shows considerable promise due to its vast population and expanding healthcare infrastructure. Brazil allocates approximately 9.47% of its GDP to healthcare, translating to around US$ 161 billion. The country has a robust healthcare system, with a significant number of private hospitals and healthcare providers. In 2022, pharmaceutical sales in Brazil reached US$ 20.67 billion, reflecting a 26.2% increase from the previous year.
The aging population in Brazil is also a critical factor, with projections indicating that by 2030, nearly 24% of the population will be aged 60 and above. This demographic shift is expected to drive demand for pharmaceuticals, particularly in the areas of chronic disease management and geriatric care. The high incidence of cancer in Brazil, with over 627,000 cases reported in 2022, further emphasizes the need for effective pharmaceutical interventions.
Key Players in the Market
The pharmaceuticals market is home to several prominent companies, including GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, and Novartis AG, among others. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to consumers.
In summary, the South and Central America pharmaceuticals market is on a path of robust growth, driven by demographic changes, healthcare advancements, and increasing demand for medical treatments. The evolving landscape presents both challenges and opportunities for stakeholders in the industry.
Market Overview and Growth Drivers
The South and Central America pharmaceuticals market is primarily segmented into key countries, notably Brazil and Argentina, along with other nations in the region. The expansion of this market can be attributed to several critical factors, including a large and growing population, improvements in healthcare infrastructure, increased government investment in healthcare innovation, rising healthcare expenditures, and a heightened demand for medical treatments due to the increasing prevalence of chronic diseases.
Countries like Costa Rica and Brazil are emerging as attractive destinations for medical tourism, offering high-quality healthcare services at competitive prices. This influx of international patients seeking medical care has significantly boosted the demand for pharmaceuticals, particularly as more individuals pursue elective surgeries, cosmetic procedures, and specialized treatments. Brazil, in particular, is home to numerous Joint Commission International (JCI)-accredited hospitals and clinics, ensuring that patients receive care that meets international standards. The state of Pernambuco, with its capital Recife, has become a notable hub for medical tourism, housing over 2,000 healthcare facilities. In 2022, more than 120,000 medical tourists visited Recife for treatment, underscoring the region's growing reputation in the healthcare sector.
Market Segmentation Insights
The South and Central America pharmaceuticals market can be analyzed through various lenses:
- By Molecule Type: The market is divided into Small Molecule and Biological/Biosimilar Products, with Small Molecule products holding the largest market share in 2024.
- By Indication: The market is categorized into several therapeutic areas, including Metabolic Diseases, Cancer, Immunology, Respiratory Disorders, Cardiovascular Disorders, Neurology Disorders, Rare Diseases, and others. Cancer treatments are expected to dominate this segment in 2024.
- By Product Type: The market is further segmented into Branded and Generic pharmaceuticals, with Branded products leading the market share.
- By Drug Type: The market is divided into Prescription and Over-the-Counter (OTC) drugs, with Prescription drugs holding the largest share.
- By Distribution Channel: The distribution of pharmaceuticals occurs through Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, with Hospital Pharmacies being the most significant channel in 2024.
The future of the South and Central America pharmaceuticals market is characterized by a shift in power dynamics, with emerging regional players redefining the landscape of pharmaceutical innovation and market focus. Supply chains are expected to diversify strategically, reducing reliance on traditional hubs and enhancing agility in response to global uncertainties. Regulatory frameworks are also anticipated to evolve, incorporating digital tools and fostering cross-border collaborations to streamline approval processes.
According to Oxford Economics, the global pharmaceuticals market, valued at US$ 1.5 trillion in 2023, is on a steady growth trajectory, with expected expansions of 3% in 2024, 4% in 2025, and 3.6% in 2026. This growth is influenced by changing healthcare needs, shifts in supply chains, and evolving regulatory environments. The pharmaceutical industry is undergoing a transformation driven by these factors, alongside increasing demand for specialized medicines and a wave of mergers and acquisitions that are reshaping the competitive landscape. Challenges such as regulatory complexities and cost pressures remain, necessitating greater agility and innovation within the sector.
Country-Specific Insights
Focusing on Brazil, the largest market in the region, the pharmaceuticals sector shows considerable promise due to its vast population and expanding healthcare infrastructure. Brazil allocates approximately 9.47% of its GDP to healthcare, translating to around US$ 161 billion. The country has a robust healthcare system, with a significant number of private hospitals and healthcare providers. In 2022, pharmaceutical sales in Brazil reached US$ 20.67 billion, reflecting a 26.2% increase from the previous year.
The aging population in Brazil is also a critical factor, with projections indicating that by 2030, nearly 24% of the population will be aged 60 and above. This demographic shift is expected to drive demand for pharmaceuticals, particularly in the areas of chronic disease management and geriatric care. The high incidence of cancer in Brazil, with over 627,000 cases reported in 2022, further emphasizes the need for effective pharmaceutical interventions.
Key Players in the Market
The pharmaceuticals market is home to several prominent companies, including GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, and Novartis AG, among others. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to consumers.
In summary, the South and Central America pharmaceuticals market is on a path of robust growth, driven by demographic changes, healthcare advancements, and increasing demand for medical treatments. The evolving landscape presents both challenges and opportunities for stakeholders in the industry.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
3.3 Assumptions and Limitations
4. PHARMACEUTICAL MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Regulatory Landscape
4.3.1 South & Central America
4.3.1.1 Brazil
4.4 List of Key Suppliers:
4.5 Average selling Price:
4.6 Sourcing Strategy:
4.7 Market Entry Barriers in the Global Pharmaceutical Market:
4.8 Top 10 Blockbuster Drugs Facing Patent Expiry in the Next 5 Years with Revenue Data and Market Impact:
5. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET – KEY MARKET DYNAMICS
5.1 South & Central America Pharmaceutical Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Global Disease Burden and Increasing Demand for Innovative Treatments
5.2.2 Expanding Global Access to Medicines and Growing Emerging Markets
5.3 Market Restraints
5.3.1 Regulatory Pressures and Market Shifts
5.4 Market Opportunities
5.4.1 Harnessing Innovation, AI, and Market Expansion
5.5 Future Trends
5.5.1 Regional Power Shifts, Supply Chain Diversification, and Regulatory Evolution
5.6 Impact of Drivers and Restraints:
6. PHARMACEUTICAL MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Pharmaceutical Market Revenue (US$ Billion), 2021–2031
6.2 South & Central America Pharmaceutical Market Forecast Analysis
7. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY MOLECULE TYPE
7.1 Small Molecule
7.1.1 Overview
7.1.2 Small Molecule: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
7.2 Biological and Biosimilar Products
7.2.1 Overview
7.2.2 Biological and Biosimilar Products: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY INDICATION
8.1 Metabolic Diseases
8.1.1 Overview
8.1.2 Metabolic Diseases: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.2 Cancer
8.2.1 Overview
8.2.2 Cancer: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.3 Immunology
8.3.1 Overview
8.3.2 Immunology: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.4 Respiratory Disorder
8.4.1 Overview
8.4.2 Respiratory Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.5 Cardiovascular Disorder
8.5.1 Overview
8.5.2 Cardiovascular Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.6 Neurology Disorder
8.6.1 Overview
8.6.2 Neurology Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.7 Rare Disease
8.7.1 Overview
8.7.2 Rare Disease: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
9. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY PRODUCT
9.1 Branded
9.1.1 Overview
9.1.2 Branded: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
9.2 Generic
9.2.1 Overview
9.2.2 Generic: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
10. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY TYPE
10.1 Prescription
10.1.1 Overview
10.1.2 Prescription: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
10.2 OTC Drugs
10.2.1 Overview
10.2.2 OTC Drugs: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
11. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
12.1 South & Central America
12.1.1 South & Central America Pharmaceutical Market – Revenue and Forecast Analysis – by Country
12.1.1.1 South & Central America Pharmaceutical Market – Revenue and Forecast Analysis – by Country
12.1.1.2 Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.1.2.1 Brazil: South & Central America Pharmaceutical Market Share – by Molecule Type
12.1.1.2.2 Brazil: South & Central America Pharmaceutical Market Share – by Indication
12.1.1.2.3 Brazil: South & Central America Pharmaceutical Market Share – by Product
12.1.1.2.4 Brazil: South & Central America Pharmaceutical Market Share – by Type
12.1.1.2.5 Brazil: South & Central America Pharmaceutical Market Share – by Distribution Channel
12.1.1.3 Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.1.3.1 Argentina: South & Central America Pharmaceutical Market Share – by Molecule Type
12.1.1.3.2 Argentina: South & Central America Pharmaceutical Market Share – by Indication
12.1.1.3.3 Argentina: South & Central America Pharmaceutical Market Share – by Product
12.1.1.3.4 Argentina: South & Central America Pharmaceutical Market Share – by Type
12.1.1.3.5 Argentina: South & Central America Pharmaceutical Market Share – by Distribution Channel
12.1.1.4 Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.1.4.1 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Molecule Type
12.1.1.4.2 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Indication
12.1.1.4.3 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Product
12.1.1.4.4 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Type
12.1.1.4.5 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Distribution Channel
13. COMPETITIVE LANDSCAPE
13.1 Company Market Share Analysis
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Expansion
14.3 New Product Development
14.4 Merger and Acquisition
14.5 Partnerships
14.6 Other Business Strategies
15. COMPANY PROFILES
15.1 Johnson & Johnson
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Pfizer Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Merck & Co Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Eli Lilly and Co
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 SWOT Analysis
15.4.5 Key Developments
15.5 Bristol-Myers Squibb Co
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 ESTEVE
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 UCB SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Teva Pharmaceutical Industries Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Hikma Pharmaceuticals Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Viatris Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 AstraZeneca Plc
15.11.1 1Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Sanofi SA
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
15.13 GSK Plc
15.13.1 Key Facts
15.13.2 Business Description
15.13.3 Products and Services
15.13.4 Financial Overview
15.13.5 SWOT Analysis
15.13.6 Key Developments
15.14 F. Hoffmann-La Roche Ltd
15.14.1 Key Facts
15.14.2 Business Description
15.14.3 Products and Services
15.14.4 Financial Overview
15.14.5 SWOT Analysis
15.14.6 Key Developments
15.15 Novartis AG
15.15.1 Key Facts
15.15.2 Business Description
15.15.3 Products and Services
15.15.4 Financial Overview
15.15.5 SWOT Analysis
15.15.6 Key Developments
15.16 AbbVie Inc
15.16.1 Key Facts
15.16.2 Business Description
15.16.3 Products and Services
15.16.4 Financial Overview
15.16.5 SWOT Analysis
15.16.6 Key Developments
16. APPENDIX
16.1 Glossary of Terms
16.2 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
3.3 Assumptions and Limitations
4. PHARMACEUTICAL MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Regulatory Landscape
4.3.1 South & Central America
4.3.1.1 Brazil
4.4 List of Key Suppliers:
4.5 Average selling Price:
4.6 Sourcing Strategy:
4.7 Market Entry Barriers in the Global Pharmaceutical Market:
4.8 Top 10 Blockbuster Drugs Facing Patent Expiry in the Next 5 Years with Revenue Data and Market Impact:
5. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET – KEY MARKET DYNAMICS
5.1 South & Central America Pharmaceutical Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Global Disease Burden and Increasing Demand for Innovative Treatments
5.2.2 Expanding Global Access to Medicines and Growing Emerging Markets
5.3 Market Restraints
5.3.1 Regulatory Pressures and Market Shifts
5.4 Market Opportunities
5.4.1 Harnessing Innovation, AI, and Market Expansion
5.5 Future Trends
5.5.1 Regional Power Shifts, Supply Chain Diversification, and Regulatory Evolution
5.6 Impact of Drivers and Restraints:
6. PHARMACEUTICAL MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Pharmaceutical Market Revenue (US$ Billion), 2021–2031
6.2 South & Central America Pharmaceutical Market Forecast Analysis
7. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY MOLECULE TYPE
7.1 Small Molecule
7.1.1 Overview
7.1.2 Small Molecule: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
7.2 Biological and Biosimilar Products
7.2.1 Overview
7.2.2 Biological and Biosimilar Products: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY INDICATION
8.1 Metabolic Diseases
8.1.1 Overview
8.1.2 Metabolic Diseases: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.2 Cancer
8.2.1 Overview
8.2.2 Cancer: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.3 Immunology
8.3.1 Overview
8.3.2 Immunology: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.4 Respiratory Disorder
8.4.1 Overview
8.4.2 Respiratory Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.5 Cardiovascular Disorder
8.5.1 Overview
8.5.2 Cardiovascular Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.6 Neurology Disorder
8.6.1 Overview
8.6.2 Neurology Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.7 Rare Disease
8.7.1 Overview
8.7.2 Rare Disease: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
9. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY PRODUCT
9.1 Branded
9.1.1 Overview
9.1.2 Branded: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
9.2 Generic
9.2.1 Overview
9.2.2 Generic: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
10. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY TYPE
10.1 Prescription
10.1.1 Overview
10.1.2 Prescription: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
10.2 OTC Drugs
10.2.1 Overview
10.2.2 OTC Drugs: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
11. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12. SOUTH & CENTRAL AMERICA PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
12.1 South & Central America
12.1.1 South & Central America Pharmaceutical Market – Revenue and Forecast Analysis – by Country
12.1.1.1 South & Central America Pharmaceutical Market – Revenue and Forecast Analysis – by Country
12.1.1.2 Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.1.2.1 Brazil: South & Central America Pharmaceutical Market Share – by Molecule Type
12.1.1.2.2 Brazil: South & Central America Pharmaceutical Market Share – by Indication
12.1.1.2.3 Brazil: South & Central America Pharmaceutical Market Share – by Product
12.1.1.2.4 Brazil: South & Central America Pharmaceutical Market Share – by Type
12.1.1.2.5 Brazil: South & Central America Pharmaceutical Market Share – by Distribution Channel
12.1.1.3 Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.1.3.1 Argentina: South & Central America Pharmaceutical Market Share – by Molecule Type
12.1.1.3.2 Argentina: South & Central America Pharmaceutical Market Share – by Indication
12.1.1.3.3 Argentina: South & Central America Pharmaceutical Market Share – by Product
12.1.1.3.4 Argentina: South & Central America Pharmaceutical Market Share – by Type
12.1.1.3.5 Argentina: South & Central America Pharmaceutical Market Share – by Distribution Channel
12.1.1.4 Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
12.1.1.4.1 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Molecule Type
12.1.1.4.2 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Indication
12.1.1.4.3 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Product
12.1.1.4.4 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Type
12.1.1.4.5 Rest of South & Central America: South & Central America Pharmaceutical Market Share – by Distribution Channel
13. COMPETITIVE LANDSCAPE
13.1 Company Market Share Analysis
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Expansion
14.3 New Product Development
14.4 Merger and Acquisition
14.5 Partnerships
14.6 Other Business Strategies
15. COMPANY PROFILES
15.1 Johnson & Johnson
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Pfizer Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Merck & Co Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Eli Lilly and Co
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 SWOT Analysis
15.4.5 Key Developments
15.5 Bristol-Myers Squibb Co
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 ESTEVE
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 UCB SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Teva Pharmaceutical Industries Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Hikma Pharmaceuticals Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Viatris Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 AstraZeneca Plc
15.11.1 1Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Sanofi SA
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
15.13 GSK Plc
15.13.1 Key Facts
15.13.2 Business Description
15.13.3 Products and Services
15.13.4 Financial Overview
15.13.5 SWOT Analysis
15.13.6 Key Developments
15.14 F. Hoffmann-La Roche Ltd
15.14.1 Key Facts
15.14.2 Business Description
15.14.3 Products and Services
15.14.4 Financial Overview
15.14.5 SWOT Analysis
15.14.6 Key Developments
15.15 Novartis AG
15.15.1 Key Facts
15.15.2 Business Description
15.15.3 Products and Services
15.15.4 Financial Overview
15.15.5 SWOT Analysis
15.15.6 Key Developments
15.16 AbbVie Inc
15.16.1 Key Facts
15.16.2 Business Description
15.16.3 Products and Services
15.16.4 Financial Overview
15.16.5 SWOT Analysis
15.16.6 Key Developments
16. APPENDIX
16.1 Glossary of Terms
16.2 About The Insight Partners
LIST OF TABLES
Table 1. South & Central America Pharmaceutical Market Segmentation
Table 2. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Table 3. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Molecule Type
Table 4. Table: Top-Selling Drugs in 2021
Table 5. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Indication
Table 6. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Product
Table 7. Key brands facing patent expirations
Table 8. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Type
Table 9. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Distribution Channel
Table 10. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Country
Table 11. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Molecule Type
Table 12. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Indication
Table 13. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Product
Table 14. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Type
Table 15. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Distribution Channel
Table 16. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Molecule Type
Table 17. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Indication
Table 18. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Product
Table 19. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Type
Table 20. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Distribution Channel
Table 21. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Molecule Type
Table 22. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Indication
Table 23. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Product
Table 24. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Type
Table 25. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Distribution Channel
Table 26. Company Market Share Analysis
Table 27. Glossary of Terms, Pharmaceutical Market
Table 1. South & Central America Pharmaceutical Market Segmentation
Table 2. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Table 3. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Molecule Type
Table 4. Table: Top-Selling Drugs in 2021
Table 5. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Indication
Table 6. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Product
Table 7. Key brands facing patent expirations
Table 8. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Type
Table 9. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Distribution Channel
Table 10. South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion) – by Country
Table 11. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Molecule Type
Table 12. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Indication
Table 13. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Product
Table 14. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Type
Table 15. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Distribution Channel
Table 16. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Molecule Type
Table 17. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Indication
Table 18. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Product
Table 19. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Type
Table 20. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Distribution Channel
Table 21. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Molecule Type
Table 22. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Indication
Table 23. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Product
Table 24. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Type
Table 25. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021 – 2031(US$ Billion) – by Distribution Channel
Table 26. Company Market Share Analysis
Table 27. Glossary of Terms, Pharmaceutical Market
LIST OF FIGURES
Figure 1. South & Central America Pharmaceutical Market Segmentation – Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Pharmaceutical Market Revenue (US$ Billion), 2021–2031
Figure 5. South & Central America Pharmaceutical Market Share (%) – by Molecule Type (2024 and 2031)
Figure 6. Small Molecule: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 7. Biological and Biosimilar Products: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 8. South & Central America Pharmaceutical Market Share (%) – by Indication (2024 and 2031)
Figure 9. Metabolic Diseases: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 10. Cancer: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 11. Immunology: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 12. Respiratory Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 13. Cardiovascular Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 14. Neurology Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 15. Rare Disease: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 16. Others: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 17. South & Central America Pharmaceutical Market Share (%) – by Product (2024 and 2031)
Figure 18. Branded: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 19. Generic: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 20. South & Central America Pharmaceutical Market Share (%) – by Type (2024 and 2031)
Figure 21. Prescription: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 22. OTC Drugs: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 23. South & Central America Pharmaceutical Market Share (%) – by Distribution Channel (2024 and 2031)
Figure 24. Hospital Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 25. Retail Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 26. Online Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 27. South & Central America Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 28. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021– 2031 (US$ Billion)
Figure 29. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021– 2031 (US$ Billion)
Figure 30. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021– 2031 (US$ Billion)
Figure 1. South & Central America Pharmaceutical Market Segmentation – Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Pharmaceutical Market Revenue (US$ Billion), 2021–2031
Figure 5. South & Central America Pharmaceutical Market Share (%) – by Molecule Type (2024 and 2031)
Figure 6. Small Molecule: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 7. Biological and Biosimilar Products: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 8. South & Central America Pharmaceutical Market Share (%) – by Indication (2024 and 2031)
Figure 9. Metabolic Diseases: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 10. Cancer: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 11. Immunology: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 12. Respiratory Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 13. Cardiovascular Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 14. Neurology Disorder: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 15. Rare Disease: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 16. Others: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 17. South & Central America Pharmaceutical Market Share (%) – by Product (2024 and 2031)
Figure 18. Branded: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 19. Generic: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 20. South & Central America Pharmaceutical Market Share (%) – by Type (2024 and 2031)
Figure 21. Prescription: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 22. OTC Drugs: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 23. South & Central America Pharmaceutical Market Share (%) – by Distribution Channel (2024 and 2031)
Figure 24. Hospital Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 25. Retail Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 26. Online Pharmacies: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021–2031 (US$ Billion)
Figure 27. South & Central America Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 28. Brazil: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021– 2031 (US$ Billion)
Figure 29. Argentina: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021– 2031 (US$ Billion)
Figure 30. Rest of South & Central America: South & Central America Pharmaceutical Market – Revenue and Forecast, 2021– 2031 (US$ Billion)
